Homozygous variant in LMF-1 identified in 3 Colombian families
Journal of Clinical Lipidology · 2026
DOI: 10.1016/j.jacl.2026.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026. Verfasst von Santiago Vallejo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario San Jorge de Pereira, Colombia (Dr Vallejo). Hauptthemen laut MEDLINE: Homozygote, Hyperlipoproteinemia Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by extreme hypertriglyceridemia (>1000 mg/dL), recurrent pancreatitis, and lipoprotein lipase (LPL) deficiency. FCS is caused by biallelic loss-of-function variants in LPL or in 4 other genes encoding its cofactors and regulators, including LMF1 (lipase maturation factor 1). Variants in LMF1 are rare and present only in 1% to 2% of the FCS cases. OBJECTIVE: To assess in 3 patients with severe hypertriglyceridemia and recurrent pancreatitis and in whom a homozygous LMF1 duplication, initially classified as a variant of uncertain significance (VUS) was identified, post-heparin LPL activity. METHODS: We collected demographics, fasting lipid profiles, and body mass index, and performed next-generation sequencing using a targeted panel that included canonical FCS genes. A homozygous in-frame duplication in LMF1 (c.914_928dup; p.Ser309_Phe310dup) was identified. Variants were classified according to American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines and cross-referenced with public archive of reports of the relationships among human variations and phenotypes (ClinVar), The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff (HGMD), Leiden Open Variation Database (LOVD), The Single Nucleotide Polymorphism database (dbSNP), The Genome Aggregation Database (gnomAD), and in-house databases. LPL activity was assessed in post-heparin plasma using a radiometric assay. RESULTS: All 3 patients were homozygous for c.914_928dup (this variant was classified as a VUS) and exhibited markedly reduced LPL activity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario San Jorge de Pereira, Colombia (Dr Vallejo).
- Clínica Comfamiliar Risaralda, Colombia (Drs Armijos, Escobar, and Jaramillo).
- Hospital Universitario del Quindío San Juan de Dios, Armenia, Colombia (Dr Perez).
- Clínica San Rafael, Pereira, Colombia (Dr Nova).
- Medicina Interna Universidad CES, Clínica del Campestre, Medellín, Colombia (Dr Gonzalez).
- Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina (Fariña and Dr Berg).
Zitieren
APA
Vallejo, S., Armijos, J. C., Estrada Escobar, R. A., Perez, M., Jaramillo, P., Nova, A., Gonzalez, J., Fariña, G., Berg, G., Valero, R., & Nogueira, J. P. (2026). Homozygous variant in LMF-1 identified in 3 Colombian families. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2026.01.005
Vancouver
Vallejo S, Armijos JC, Estrada Escobar RA, Perez M, Jaramillo P, Nova A, et al. Homozygous variant in LMF-1 identified in 3 Colombian families. Journal of Clinical Lipidology. 2026. doi:10.1016/j.jacl.2026.01.005
BibTeX
@article{Vallejo2026,
author = {Vallejo, Santiago and Armijos, Jessica Cristina and Estrada Escobar, Ricardo Andres and Perez, Manuel and Jaramillo, Pablo and Nova, Alejandra and Gonzalez, Juanita and Fariña, Gregorio and Berg, Gabriela and Valero, Rene and Nogueira, Juan Patricio},
title = {Homozygous variant in LMF-1 identified in 3 Colombian families},
journal = {Journal of Clinical Lipidology},
year = {2026},
doi = {10.1016/j.jacl.2026.01.005}
}
EUVIMED